{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2020", "item": "https://www.patentleaderboard.com/2020/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2020/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Chris Limberakis", "item": "https://www.patentleaderboard.com/2020/inventor/fl:ch_ln:limberakis-2"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
CL

Chris Limberakis — 4 Patents in 2020

Pfizer: 4 patents #15 of 411Top 4%
Pawcatuck, CT: #1 of 5 inventorsTop 20%
Connecticut: #393 of 4,387 inventorsTop 9%
Overall (2020): #57,889 of 565,922Top 15%
4 Patents 2020

Issued Patents 2020

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10851081 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more 2020-12-01 $390,003,000
10683281 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan +8 more 2020-06-16 $1,092,312,000
10676465 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan +8 more 2020-06-09 $602,135,000
10669259 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more 2020-06-02 $395,652,000